View larger 
ENZYMATIC CELL FORTE IP-6 & INOSITOL POWDER 414 G
New product
Since the 1950s, niacin (vitamin B3) has been known to lower blood cholesterol and triglyceride levels. In fact, in numerous clinical studies niacin has demonstrated better overall results in reducing risk factors for coronary heart disease than other cholesterol-lowering agents, including statin drugs.
Nonetheless, many people are reluctant to use niacin because at the dosing levels recommended to lower cholesterol, it causes a hot, itchy skin reaction known as the “niacin flush”.
This problem has now been overcome with the development of 'intermediate release' preparations that achieve a similar therapeutic effect with significantly lower doses, released over a shorter 6–8 hour period. Very large clinical trials have shown intermediate-release niacin preparations to be extremely well tolerated, with no liver toxicity or serious side effects noted.
